不明原因不孕夫妇的循证治疗指南
美国生殖医学学会(ASRM)基于1968至2019年文献(含88项相关研究)制定循证指南,评估不明原因不孕多种治疗的有效性与安全性。指南推荐多数夫妇首选口服药物卵巢刺激联合宫腔内人工授精(OS-IUI),通常3或4个周期,失败后行体外受精。
要点
- 不明原因不孕的治疗本质上是经验性的。
- 多数夫妇初始治疗首选口服药物卵巢刺激联合宫腔内人工授精(OS-IUI)。
- OS-IUI通常进行3或4个周期,失败后建议体外受精。
核心结论
- 不明原因不孕的治疗因缺乏明确病因,本质上为经验性治疗。
- 对多数夫妇,最佳初始治疗为口服药物卵巢刺激联合宫腔内人工授精(OS-IUI),通常3或4个周期,失败后行体外受精。
研究设计与样本
- ASRM开展文献检索,纳入1968年至2019年发表的系统综述、荟萃分析、随机对照试验及前瞻性和回顾性比较观察性研究。
- ASRM实践委员会与专家工作组基于现有证据和非正式共识制定循证指南推荐。
- 文献检索共识别88项相关研究作为该指南的证据基础。
主要发现
- 文献检索共识别88项相关研究,用于构建该指南的证据基础。
关键数值与推荐
- 指南针对以下治疗形成循证推荐:自然周期联合宫腔内人工授精(IUI);克罗米芬联合 intercourse;芳香化酶抑制剂联合 intercourse;促性腺激素联合 intercourse;克罗米芬联合IUI;芳香化酶抑制剂联合IUI;克罗米芬或来曲唑与促性腺激素(低剂量和常规剂量)联合IUI;低剂量促性腺激素联合IUI;常规剂量促性腺激素联合IUI;IUI时机;体外受精及治疗范式。
- 指南关注结局包括:活产率、临床妊娠率、着床率、受精率、多胎妊娠率、治疗剂量、卵巢过度刺激率、流产率和异位妊娠率。
临床怎么用
- 对多数不明原因不孕夫妇,初始治疗可选择口服药物卵巢刺激联合宫腔内人工授精(OS-IUI),通常进行3或4个周期。
- 若OS-IUI治疗未成功,后续建议行体外受精。
局限性
- 不明原因不孕的治疗因缺乏明确病因,本质上为经验性治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide evidence-based recommendations to practicing physicians and others regarding the effectiveness and safety of therapies for unexplained infertility. METHODS: ASRM conducted a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 1968 through 2019. The ASRM Practice Committee and a task force of experts used available evidence and informal consensus to develop evidence-based guideline recommendations. MAIN OUTCOME MEASURE(S): Outcomes of interest included: live-birth rate, clinical pregnancy rate, implantation rate, fertilization rate, multiple pregnancy rate, dose of treatment, rate of ovarian hyperstimulation, abortion rate, and ectopic pregnancy rate. RESULT(S): The literature search identified 88 relevant studies to inform the evidence base for this guideline. RECOMMENDATION(S): Evidence-based recommendations were developed for the following treatments for couples with unexplained infertility: natural cycle with intrauterine insemination (IUI); clomiphene citrate with intercourse; aromatase inhibitors with intercourse; gonadotropins with intercourse; clomiphene citrate with IUI; aromatase inhibitors with IUI; combination of clomiphene citrate or letrozole and gonadotropins (low dose and conventional dose) with IUI; low-dose gonadotropins with IUI; conventional-dose gonadotropins with IUI; timing of IUI; and in vitro fertilization and treatment paradigms. CONCLUSION(S): The treatment of unexplained infertility is by necessity empiric. For most couples, the best initial therapy is a course (typically 3 or 4 cycles) of ovarian stimulation with oral medications and intrauterine insemination (OS-IUI) followed by in vitro fertilization for those unsuccessful with OS-IUI treatments.
引用
- Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020. PMID: 32106976. doi:10.1016/j.fertnstert.2019.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。